TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34364702

Group type: EXPERIMENTAL
Intervention: Battlefield acupuncture (BFA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard pharmacologic therapies (Control)
Number of subjects: 52
Study: 33037261

Group type: EXPERIMENTAL
Intervention: Combined training (CT) - resistance training and aerobic training, 60 min, three times a week for 12 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (CG) - no intervention
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Combined training (CT)
Number of subjects: 37
Study: 36111518

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural group therapy for insomnia (CBGT-I)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study: 33785660

Group type: EXPERIMENTAL
Intervention: YogaMT (yoga exercises and medial thrust gait)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Knee-strengthening group (quadriceps and hamstring strengthening exercises)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Treadmill walking group (normal treadmill walking)
Number of subjects: 59
Study: 32132827

Group type: EXPERIMENTAL
Intervention: Static stretching for 3 minutes (3 × 60 s)
Number of subjects: 14
Study: 33084818

Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral steroid and cyclosporine‐A (immune modulator therapy)
Number of subjects: 20
Study: 33835084

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT) guided by left ventricular outflow tract velocity time integral (LVOT-VTI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Central venous pressure (CVP)-guided fluid management
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Postoperative variables (including creatinine, duration of postoperative mechanical ventilation, length of intensive care unit and hospital stay, incidence of acute kidney injury, pneumonitis, and vasospasm)
Number of subjects: 50
Study: 34849424

Group type: EXPERIMENTAL
Intervention: Randomized clinical trial (RCT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: VAS anxiety score of 5 or more
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL) – Personal development subdomain
Number of subjects: 40
Study: 35617742

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32744392

Group type: EXPERIMENTAL
Intervention: Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 35840445

Group type: EXPERIMENTAL
Intervention: Yoga Group (add-on yoga therapy and continuing prescribed medication)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (continuing prescribed medication only)
Number of subjects: 60
Study: 33237442

Group type: EXPERIMENTAL
Intervention: Elective repair
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Quality of life (PCS and MCS)
Number of subjects: 34
Study: 35392908

Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg twice daily
Number of subjects: 663

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 663
Study: 32051972

Group type: COMPARATOR
Intervention: Chlorhexidine (CHX)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Hyaluronan (HA)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Distilled Water (DW)
Number of subjects: 33
Study: 35963795

Group type: EXPERIMENTAL
Intervention: EVM+waveform
Number of subjects: 10

Group type: COMPARATOR
Intervention: EVM processed
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unprocessed
Number of subjects: 10
Study: 33482850

Group type: EXPERIMENTAL
Intervention: LIA in the deep and superficial fascia (group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: LIA in all layers (group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (group C)
Number of subjects: 120
Study: 33349641

Group type: EXPERIMENTAL
Intervention: Surgical mask (SM)
Number of subjects: 14
Study: 35377931

Group type: EXPERIMENTAL
Intervention: 3% tetracaine plus 0.05% oxymetazoline nasal spray (Kovanaze; KNS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine (LE)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3% mepivacaine plain (MP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: mock nasal spray (placebo)
Number of subjects: 20
Study: 34757343

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg (2 hours preoperative)
Number of subjects: 62
Study: 33261618

Group type: EXPERIMENTAL
Intervention: Wearable device with real-time feedback (n=29)
Number of subjects: 59

Group type: COMPARATOR
Intervention: PA measured but not visible (n=30)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups (n=59)
Number of subjects: 59
Study: 33781212

Group type: EXPERIMENTAL
Intervention: Articulated Oral Airway (AOA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Guedel Oral Airway (GOA)
Number of subjects: 58
Study: 32140889

Group type: EXPERIMENTAL
Intervention: Galunisertib plus TMZ/RTX (n = 40)
Number of subjects: 56

Group type: COMPARATOR
Intervention: TMZ/RTX (control arm, n = 16)
Number of subjects: 56
Study: 34728252

Group type: EXPERIMENTAL
Intervention: Intraoral optical scanning (IOS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional impressions
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lithium disilicate (LS2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Polymer-infiltrated ceramic networks (PICN)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Final implant restorations assessed by FIPS
Number of subjects: 40
Study: 34013356

Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 34

Group type: COMPARATOR
Intervention: Micropore tape
Number of subjects: 34
Study: 34010312

Group type: EXPERIMENTAL
Intervention: Voice call reminder intervention
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Community health volunteer (CHV) intervention with incentivized rewards
Number of subjects: 690

Group type: COMPARATOR
Intervention: Control
Number of subjects: 690
Study: 32952230

Group type: EXPERIMENTAL
Intervention: Selective upper and lower alveolar decortication and 3D collagen matrix
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Selective alveolar decortication in the upper arch, with 3D collagen matrix
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 36360714

Group type: EXPERIMENTAL
Intervention: Grit Wellbeing and Self-regulation Program (two sessions/week for six weeks)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 194
Study: 35428629

Group type: EXPERIMENTAL
Intervention: Usual care plus two 30 min rehabilitation sessions 5 days/week
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study: 33660080

Group type: EXPERIMENTAL
Intervention: Acute alcohol exposure via an aBAC clamp at 80 mg%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study: 32090783

Group type: EXPERIMENTAL
Intervention: THPP plus enhanced usual care (EUC)
Number of subjects: 850

Group type: COMPARATOR
Intervention: EUC-only
Number of subjects: 850
Study: 36137691

Group type: EXPERIMENTAL
Intervention: Rotational Atherectomy (RA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Modified Balloon (MB)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Super High-Pressure Balloon
Number of subjects: 200
Study: 34185197

Group type: EXPERIMENTAL
Intervention: Somatostatin analogues (PROMID, CLARINET)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peptide receptor radionuclide therapy (PRRT) with 177-lutetium (NETTER-1 trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mTOR inhibitor everolimus (RADIANT trials)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKI)
Number of subjects: 0
Study: 33765749

Group type: EXPERIMENTAL
Intervention: C. albicans antigen
Number of subjects: 60

Group type: COMPARATOR
Intervention: MMR vaccine
Number of subjects: 60
Study: 35926931

Group type: EXPERIMENTAL
Intervention: Ivabradine SR
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 33657007

Group type: EXPERIMENTAL
Intervention: Point-of-care CRP measurement
Number of subjects: 649
Study: 34750317

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 48

Group type: COMPARATOR
Intervention: 0.75% bupivacaine
Number of subjects: 48
Study: 34070864

Group type: EXPERIMENTAL
Intervention: Dietary substitution of polyunsaturated fatty acids for saturated fatty acids; higher concentrations of dihomo‐?‐linolenic acid (20:3n6) and palmitoleic acid (16:1n7)
Number of subjects: 7526

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted circulating dihomo‐?‐linolenic acid
Number of subjects: 7526
Study: 32513153

Group type: EXPERIMENTAL
Intervention: Treatment from a physical therapist with more knowledge about work-related factors and skills in integrating work participation into care.
Number of subjects: 442

Group type: COMPARATOR
Intervention: Normal physical therapy treatment.
Number of subjects: 442
Study: 34927239

Group type: EXPERIMENTAL
Intervention: Family Foundations program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control families
Number of subjects: 0
Study: 34820448

Group type: EXPERIMENTAL
Intervention: Different humidification devices and interfaces
Number of subjects: 0
Study: 36375186

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) denervation of the medial branch of the spinal dorsal ramus
Number of subjects: 270

Group type: COMPARATOR
Intervention: Conventional conservative approach
Number of subjects: 270
Study: 32332710

Group type: EXPERIMENTAL
Intervention: Simulations of glasses under compression with two length scales of particle interaction.
Number of subjects: 0
Study: 36278359

Group type: EXPERIMENTAL
Intervention: Compression Stockings (CS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Abdominal Binders (AB)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 16
Study: 34193047

Group type: EXPERIMENTAL
Intervention: Pantothenic acid deficient (PAD) diet
Number of subjects: 128

Group type: COMPARATOR
Intervention: Pantothenic acid adequate (control, CON) diet
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: PAD diet
Number of subjects: 128
Study: 36112182

Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrocolpopexy (LSC)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Abdominal sacrocolpopexy (ASC)
Number of subjects: 74
Study: 33599960

Group type: EXPERIMENTAL
Intervention: VP-102 (topical cantharidin 0.7% w/v)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 528
Study: 33611699

Group type: EXPERIMENTAL
Intervention: Treatment of Obstructive Sleep Apnea Syndrome (OSAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 35687774

Group type: EXPERIMENTAL
Intervention: Infraclavicular brachial plexus blockade with hydrodissection (15 mL distilled water + 15 mL 0.5% bupivacaine)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Infraclavicular brachial plexus blockade with normal method (30 mL local anesthetic mixture: 15 mL distilled water + 15 mL 0.5% bupivacaine)
Number of subjects: 90
Study: 34126133

Group type: EXPERIMENTAL
Intervention: i-gel SGA
Number of subjects: 9296

Group type: COMPARATOR
Intervention: Tracheal Intubation (TI)
Number of subjects: 9296
Study: 33096356

Group type: EXPERIMENTAL
Intervention: Active hf-tRNS (100–640 Hz; 2 mA; 20 min)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Active hf-tRNS
Number of subjects: 36
Study: 33331826

Group type: EXPERIMENTAL
Intervention: Web browser
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Federated search portal system
Number of subjects: 38

Group type: COMPARATOR
Intervention: Unassisted
Number of subjects: 38
Study: 36401445

Group type: EXPERIMENTAL
Intervention: Bicarbonated Ringer's solution (BRS)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (sodium lactate Ringer's solution)
Number of subjects: 63
Study: 32134288

Group type: EXPERIMENTAL
Intervention: Mind-body skills group (MBSG) intervention
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 108
Study: 32031737

Group type: EXPERIMENTAL
Intervention: Second-look endoscopy (SLE)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Non-second-look endoscopy (NSLE)
Number of subjects: 252
Study: 35377393

Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 312

Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 312
Study: 34138791

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) with heartbeat-music interventions (recorded maternal lullaby and heartbeat for infants, recorded infant heartbeat and preferred music for mothers)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study: 32612816

Group type: EXPERIMENTAL
Intervention: Therapeutic zinc supplements for diarrhea treatment (20 mg/d for 10 days with each episode; TZ)
Number of subjects: 3407

Group type: EXPERIMENTAL
Intervention: Daily preventive zinc tablets (7 mg/d; PZ)
Number of subjects: 3407

Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient powder (10 mg/d zinc, 6 mg/d iron and 13 other micronutrients; MNP)
Number of subjects: 3407

Group type: COMPARATOR
Intervention: Daily placebo powder
Number of subjects: 3407

Group type: EXPERIMENTAL
Intervention: Overall study group (including TZ, PZ, MNP)
Number of subjects: 3407
Study: 33955628

Group type: EXPERIMENTAL
Intervention: Foam containing nicotinic acid hexyl ester, polyphenols, zinc, glycine, and caffeine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Vehicle control foam
Number of subjects: 62
Study: 33793261

Group type: EXPERIMENTAL
Intervention: Distinctive encoding (generate a distinctive feature of the designated target)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Shared encoding (generate a shared feature of all exemplars)
Number of subjects: 2
Study: 32913174

Group type: EXPERIMENTAL
Intervention: Depilatory cream
Number of subjects: 80

Group type: COMPARATOR
Intervention: Razor shaving
Number of subjects: 80
Study: 36042635

Group type: EXPERIMENTAL
Intervention: Integrative medicine treatments (acupuncture including electroacupuncture, moxibustion, manual therapy-type massage)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional medical treatments (anti-inflammatory drugs and lifestyle change education)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SF-36 (physical role restriction area and mental health area)
Number of subjects: 30
Study: 33078649

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) group counseling for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 36375479

Group type: EXPERIMENTAL
Intervention: Rituximab (1000 mg at weeks 0 and 2 intravenously)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cyclophosphamide (600 mg/m2 body surface area every 4 weeks intravenously for six doses)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 101
Study: 34098442

Group type: EXPERIMENTAL
Intervention: Chess-training program (12-week duration, two 60-minute sessions per week)
Number of subjects: 0
Study: 36219057

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 645

Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 645
Study: 33592815

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy-based care (RTBC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control care (CC)
Number of subjects: 150
Study: 33345933

Group type: EXPERIMENTAL
Intervention: Practical Resources for Effective Postpartum Parenting
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 60
Study: 35959834

Group type: EXPERIMENTAL
Intervention: Spinal needle (25G)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Conventional needle (25G)
Number of subjects: 350
Study: 33839775

Group type: EXPERIMENTAL
Intervention: Intensive group (8 weekly in-person occupational therapy sessions with App-delivered home exercises)
Number of subjects: 32

Group type: COMPARATOR
Intervention: App Alone group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intensive group
Number of subjects: 32
Study: 33715136

Group type: EXPERIMENTAL
Intervention: FCU4Health (n=141)
Number of subjects: 240
Study: 36159170

Group type: EXPERIMENTAL
Intervention: Routine ministration with health education
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine ministration care (Control)
Number of subjects: 200
Study: 33630447

Group type: EXPERIMENTAL
Intervention: Robotic Ventral Hernia Repair (RVHR)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Laparoscopic Ventral Hernia Repair (LVHR)
Number of subjects: 124
Study: 32755531

Group type: EXPERIMENTAL
Intervention: RSV group A (78.7%)
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: RSV group B (21.3%)
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: RSV-A genotype ON1 (98.0%)
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: RSV-A genotype NA1 (2.0%)
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: RSV-B genotype BA10
Number of subjects: 1417
Study: 35834516

Group type: EXPERIMENTAL
Intervention: PFO closure procedure
Number of subjects: 971
Study: 33378563

Group type: EXPERIMENTAL
Intervention: Dynamic light that changed spectrum and intensity across the scheduled 16-h waking day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Static light
Number of subjects: 14
Study: 32731011

Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (20-minute session)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (20-minute case study session)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study: 36284013

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (0.2 mg) plus low-dose bupivacaine (0.25% Marcaine in 4 mL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine plus bupivacaine
Number of subjects: 40
Study: 32078692

Group type: EXPERIMENTAL
Intervention: Second-generation HydroCoil Embolic System (HES)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Bare platinum coil (BPC)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Both HES and BPC
Number of subjects: 600
Study: 35604789

Group type: EXPERIMENTAL
Intervention: Insurance-mediated implicit bias
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Racial-Ethnic-mediated implicit bias
Number of subjects: 109
Study: 33305474

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 50 U
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 100 U
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 200 U
Number of subjects: 100
Study: 35922961

Group type: EXPERIMENTAL
Intervention: Intraneural facilitation (INF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 28
Study: 32037254

Group type: EXPERIMENTAL
Intervention: Moderate-intensity statin therapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Low-intensity statin therapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: High Lp(a) group (Lp(a) >20 mg/dl)
Number of subjects: 102
Study: 35421070

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Coaching (CBC)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Waitlist Control Group
Number of subjects: 98
Study: 34334070

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 7
Study: 33731180

Group type: EXPERIMENTAL
Intervention: Clamping of chest drain
Number of subjects: 122

Group type: COMPARATOR
Intervention: Non-clamping of chest drain
Number of subjects: 122
Study: 32248805

Group type: EXPERIMENTAL
Intervention: Synbiotics supplementation
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 35057557

Group type: EXPERIMENTAL
Intervention: Glucose ingestion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Protein ingestion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fat ingestion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mixed-meal ingestion
Number of subjects: 36
Study: 32198616

Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 0
Study: 33821937

Group type: EXPERIMENTAL
Intervention: 12 week weight-management program
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: 52 week weight-management program
Number of subjects: 1267

Group type: COMPARATOR
Intervention: Brief intervention (booklet on losing weight)
Number of subjects: 1267
Study: 33283766

Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg/day) + Amoxicillin (1 g/12 h) + Dexlansoprazole (60 mg/day) for 7 days
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg/day) + Amoxicillin (1 g/12 h) + Dexlansoprazole (60 mg/day) for 10 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Laboratory tests before and after treatment
Number of subjects: 66
Study: 36334050

Group type: COMPARATOR
Intervention: WBRT (30 Gy) ± 10 Gy boost (arm A)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: WBRT ± boost with concomitant and maintenance TMZ for 2 years (arm B)
Number of subjects: 134
Study: 34438976

Group type: EXPERIMENTAL
Intervention: Subgingival instrumentation (SI) with local adjunctive use of hyaluronic acid (HA) gel
Number of subjects: 126

Group type: COMPARATOR
Intervention: Adjunctive use of local placebo
Number of subjects: 126
Study: 32568196

Group type: EXPERIMENTAL
Intervention: Crenezumab 30 or 45 mg/kg intravenously every 4 weeks for 13 weeks
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Crenezumab 60 mg/kg intravenously every 4 weeks for 13 weeks
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Crenezumab 120 mg/kg intravenously every 4 weeks for 13 weeks
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Crenezumab during open-label extension (OLE) at originally assigned dose level, except for Cohort 3 (crenezumab 60 mg/kg during OLE)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71